Combination treatment with intrahepatic arterial infusion and intratumoral injection chemotherapy in patients with far-advanced hepatocellular carcinoma and arterioportal or arteriovenous shunts: preliminary results
Ja Seon Kim, Young Min Park, Nha Young Kim, Han Kyeol Yun, Ki Jong Lee, Bo Hyun Kim, Sang Jong Park, Jae Woo Yeon, Guhung Jung
Korean J Hepatol. 2011;17(2):120-129.   Published online 2011 Jun 23     DOI:
Citations to this article as recorded by Crossref logo
diTFPP, a Phenoxyphenol, Sensitizes Hepatocellular Carcinoma Cells to C2-Ceramide-Induced Autophagic Stress by Increasing Oxidative Stress and ER Stress Accompanied by LAMP2 Hypoglycosylation
Chien-Chih Chiu, Yen-Chun Chen, Yung-Ding Bow, Jeff Yi-Fu Chen, Wangta Liu, Jau-Ling Huang, En-De Shu, Yen-Ni Teng, Chang-Yi Wu, Wen-Tsan Chang
Cancers.2022; 14(10): 2528.     CrossRef
Fluoropyrimidine Modulation of the Anti-Tumor Immune Response―Prospects for Improved Colorectal Cancer Treatment
William H. Gmeiner
Cancers.2020; 12(6): 1641.     CrossRef
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Flávia Castro, Ana Patrícia Cardoso, Raquel Madeira Gonçalves, Karine Serre, Maria José Oliveira
Frontiers in Immunology.2018;[Epub]     CrossRef
Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model
Sibu P. Kuruvilla, Gopinath Tiruchinapally, A. Colleen Crouch, Mohamed E. H. ElSayed, Joan M. Greve, Nicola Amodio
PLOS ONE.2017; 12(8): e0181944.     CrossRef